Fig. 1From: Patient advocacy organizations’ information for patients on pre-approval access to investigational treatmentsAnalysis of patient advocacy organization (PAOs) and the extent to which they provide information and resources on clinical trials, the U.S. Food and Drug Administration’s expanded access program, and the Right to Try Act. Bars represent the percentage of PAOs that provided information on 7 different criteria presented in the “Methods” sectionBack to article page